Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2011 1
2012 3
2013 1
2014 4
2015 3
2016 2
2017 1
2020 1
2022 1
2023 3
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Psyrri A, Fayette J, Harrington K, Gillison M, Ahn MJ, Takahashi S, Weiss J, Machiels JP, Baxi S, Vasilyev A, Karpenko A, Dvorkin M, Hsieh CY, Thungappa SC, Segura PP, Vynnychenko I, Haddad R, Kasper S, Mauz PS, Baker V, He P, Evans B, Wildsmith S, Olsson RF, Yovine A, Kurland JF, Morsli N, Seiwert TY; KESTREL Investigators. Psyrri A, et al. Among authors: segura pp. Ann Oncol. 2023 Mar;34(3):262-274. doi: 10.1016/j.annonc.2022.12.008. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36535565 Free article. Clinical Trial.
Adolescent With Penile Lesions.
Campos-Muñoz L, Oancea Ionescu R, Conde-Taboada A, Segura PP, López-Bran E. Campos-Muñoz L, et al. Among authors: segura pp. Pediatr Dermatol. 2025 Jun 30. doi: 10.1111/pde.16017. Online ahead of print. Pediatr Dermatol. 2025. PMID: 40589203 No abstract available.
Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.
Adrián SG, Pérez CI, Carmona-Bayonas A, Morán LO, Pérez JR, Del Prado PM, De Castro EM, Neria F, Pérez IF, De Herreros MG, Campos MC, Escobar IG, Balanyà RP, González DM, Fonseca PJ, García MEG, Cánovas MS, Langa JM, Segura PP, Vidal MJM, Martín AJM, Medical Oncology SSO. Adrián SG, et al. Among authors: segura pp. Haematologica. 2025 Jul 1;110(7):1513-1522. doi: 10.3324/haematol.2024.286152. Epub 2024 Dec 12. Haematologica. 2025. PMID: 39665199 Free PMC article.
[Prevention of colorectal cancer].
Andreu García M, Marzo M, Mascort J, Quintero E, García-Alfonso P, López-Ibor C, Castells A, Segura PP; Alianza para la Prevención del Cáncer de Colon en España. Andreu García M, et al. Among authors: segura pp. Aten Primaria. 2009 Mar;41(3):127-8. doi: 10.1016/j.aprim.2008.12.003. Epub 2009 Mar 21. Aten Primaria. 2009. PMID: 19304348 Free PMC article. Spanish. No abstract available.
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura PP, Quintela NV, García MM, Del Barco Berrón S, Sarrió RG, Gómez JG, Castaño AG, Martín LMN, Rubio OG, Losada EP. Segura PP, et al. Clin Transl Oncol. 2023 Sep;25(9):2634-2646. doi: 10.1007/s12094-023-03245-y. Epub 2023 Aug 4. Clin Transl Oncol. 2023. PMID: 37540408 Free PMC article.
Indicators to evaluate quality of care in head and neck cancer in Spain.
Hernández JJC, Arrula VA, Álvarez YE, Castaño AG, de Castro JJG, Docampo LI, Sorrosal JL, Segura PP, Domínguez AR, Campos-Lucas FJ, Rodríguez IS, Bessa M, Gratal P, Caballero-Martínez F, Martín DM, Antón-Rodríguez C, López R. Hernández JJC, et al. Among authors: segura pp. Clin Transl Oncol. 2024 May;26(5):1089-1097. doi: 10.1007/s12094-023-03298-z. Epub 2023 Oct 17. Clin Transl Oncol. 2024. PMID: 37848694 Free PMC article.
SEOM guide to primary and secondary prevention of cancer: 2014.
Segura PP, Fombella JP, Lorenzo BP, Martín MR, Lopez PG; Spanish Society for Medical Oncology. Segura PP, et al. Clin Transl Oncol. 2014 Dec;16(12):1072-8. doi: 10.1007/s12094-014-1215-5. Epub 2014 Oct 31. Clin Transl Oncol. 2014. PMID: 25358801 Free PMC article.
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, Spurdle AB, Walker LC, Lose F, Maia AT, Montagna M, Matricardi L, Lubinski J, Jakubowska A, Gómez Garcia EB, Olopade OI, Nussbaum RL, Nathanson KL, Domchek SM, Rebbeck TR, Arun BK, Karlan BY, Orsulic S, Lester J, Chung WK, Miron A, Southey MC, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg EJ, Ding YC, Neuhausen SL, Hansen TV, Gerdes AM, Ejlertsen B, Jønson L, Osorio A, Martínez-Bouzas C, Benitez J, Conway EE, Blazer KR, Weitzel JN, Manoukian S, Peissel B, Zaffaroni D, Scuvera G, Barile M, Ficarazzi F, Mariette F, Fortuzzi S, Viel A, Giannini G, Papi L, Martayan A, Tibiletti MG, Radice P, Vratimos A, Fostira F, Garber JE, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Davidson R, Hodgson SV, Ellis S, Cole T; EMBRACE; Godwin AK, Claes K, Van Maerken T, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Plendl H, Kast K, Rhiem … See abstract for full author list ➔ Peterlongo P, et al. Among authors: segura pp. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):308-16. doi: 10.1158/1055-9965.EPI-14-0532. Epub 2014 Oct 21. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25336561 Free PMC article.
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D; EMBRACE; McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, Tesoriero A; kConFab Investigators; James PA, Bruinsma F, Campbell IG; Australia Ovarian Cancer Study Group; Broeks A, Schmidt MK, Hogervorst FB; HEBON; Beckman MW, Fasching PA, Fletcher O, Johnson N, Sawyer EJ, Riboli E, Banerjee S, Menon U, Tomlinson I, Burwinkel B, Hamann U, Marme F, Rudolph A, Janavicius R, Tihomirova L, Tung N, Garber J, Cramer D, Terry KL, Poole EM, Tworoger SS, Dorfling CM, van Rensburg EJ, Godwin AK, Guénel P, Truong T; GEMO Study Collaborators; Stoppa-Lyonnet D, Damiola F, Mazoyer S, Sinilnikova OM, Isaacs C, Maugard C, Bojesen SE, Flyger H, Gerdes AM, Hansen TV, Jensen A, Kjaer SK, Hogdall C, Hogdall E, Pedersen IS, Thomassen M, Benitez J, González-Neira A, Osorio A, Hoya Mde L, Segura PP, Diez O, Lazaro C, Brunet J, Anton-Culver H, Eunjung L, John EM, Neuhausen SL, Ding YC, Castillo D, Weitzel JN, Ganz PA, Nussbaum RL, Chan SB, Karlan BY, Lester J, Wu A, Gayther S, Ramus SJ, Sieh W, Whittermore AS, Monteiro AN, Phelan CM, Terry MB, Piedmonte M, Offit K, Robson M, Levine D, Moysich KB, Cannioto R… See abstract for full author list ➔ Meeks HD, et al. Among authors: segura pp. J Natl Cancer Inst. 2015 Nov 19;108(2):djv315. doi: 10.1093/jnci/djv315. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26586665 Free PMC article.
20 results